TH83710B - Combined therapy - Google Patents
Combined therapyInfo
- Publication number
- TH83710B TH83710B TH501005942A TH0501005942A TH83710B TH 83710 B TH83710 B TH 83710B TH 501005942 A TH501005942 A TH 501005942A TH 0501005942 A TH0501005942 A TH 0501005942A TH 83710 B TH83710 B TH 83710B
- Authority
- TH
- Thailand
- Prior art keywords
- approximately
- angiotensin
- hydrochlorothiazide
- hypertension
- treatment
- Prior art date
Links
- 238000002648 combination therapy Methods 0.000 title 1
- JZUFKLXOESDKRF-UHFFFAOYSA-N Dichlothiazide Chemical compound C1=C(Cl)C(S(=O)(=O)N)=CC2=C1NCNS2(=O)=O JZUFKLXOESDKRF-UHFFFAOYSA-N 0.000 claims abstract 4
- 229960002003 hydrochlorothiazide Drugs 0.000 claims abstract 4
- 239000000203 mixture Substances 0.000 claims abstract 4
- 206010020772 Hypertension Diseases 0.000 claims abstract 3
- 102000008873 Angiotensin II receptor Human genes 0.000 claims 2
- 108050000824 Angiotensin II receptor Proteins 0.000 claims 2
- 230000003042 antagnostic Effects 0.000 claims 2
- 239000005557 antagonist Substances 0.000 claims 2
- 230000001396 anti-anti-diuretic Effects 0.000 claims 2
- 239000002934 diuretic Substances 0.000 claims 2
- 230000001882 diuretic Effects 0.000 claims 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 239000003451 thiazide diuretic agent Substances 0.000 claims 1
- 239000002333 angiotensin II receptor antagonist Substances 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 229940079593 drugs Drugs 0.000 abstract 2
- IVRMZWNICZWHMI-UHFFFAOYSA-N azide Chemical compound [N-]=[N+]=[N-] IVRMZWNICZWHMI-UHFFFAOYSA-N 0.000 abstract 1
- 230000036772 blood pressure Effects 0.000 abstract 1
- 239000003795 chemical substances by application Substances 0.000 abstract 1
Abstract
สารผสมทางเภสัชกรรมซึ่งประกอบรวมด้วยเทลมิซาร์ทานประมาณ 80 มก. และไฮโดร คอลโรไธอะไซด์ประมาณ 25 มก. หรือเทลมิซาร์ทานประมาณ 160 มก. และไฮโดรคลอโรไธอะไซด์ ประมาณ 50 มก. สำหรับการรักษาความดันเลือดสูงในผู้ป่วยที่มีการลดลงของความดันเลือดไม่ เพียงพอเมื่อทำการรักษาด้วยตัวปฏิปักษ์ตัวรับแองจิโอเทนซิน II หรือสารผสมทางเภสัชกรรมของตัว ปฏิปักษ์ตัวรับแองจิโอเทนซิน II และไฮโดรคลอโรไธอะไซด์ที่ปริมาณยาที่ต่ำ Pharmaceutical mixtures consisting of approximately 80 mg of telmizartan and approximately 25 mg of hydrochlorothiazide, or approximately 160 mg of telmizartan and hydrochlorothiazide. Azide approximately 50 mg for the treatment of hypertension in patients with no drop in blood pressure. Adequate when treated with angiotensin II receptor antagonists or drug mixtures of the agent. Angiotensin II receptor antagonists and hydrochlorothiazide at low drug doses.
Claims (2)
Publications (2)
Publication Number | Publication Date |
---|---|
TH83710B true TH83710B (en) | 2007-03-29 |
TH83710A TH83710A (en) | 2007-03-29 |
Family
ID=
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA200701159A1 (en) | COMBINED MEDICINE INCLUDING TELMISARTAN AND HYDROCHLORTHIAZIDE | |
Barreras et al. | Angiotensin II receptor blockers | |
Kamen et al. | A practical overview of tizanidine use for spasticity secondary to multiple sclerosis, stroke, and spinal cord injury | |
CL2008003595A1 (en) | Nitrogen heterocyclic compounds, tachykinin receptor antagonists; pharmaceutical agent comprising the compound; and use in the prophylaxis or treatment of a lower urinary tract disease, a gastrointestinal disease, or a disease of the central nervous system. | |
ATE380547T1 (en) | DOUBLE-LAYER PHARMACEUTICAL TABLET CONTAINING TELMISARTAN AND HYDROCHLOROTHIAZIDE | |
EA200870325A1 (en) | MEDICAL FORMS FOR THE INTRODUCTION OF COMBINATIONS OF MEDICINES | |
PE20061195A1 (en) | BENZIMIDAZOLE DERIVATIVE AS ANGIOTENSIN II ANTAGONIST | |
ECSP055701A (en) | NEW DERIVATIVES OF PYRIMIDINAMIDE AND THE USE OF THE SAME | |
RU2004135563A (en) | MEDICINE FOR TREATING AN INCREASED ACTIVITY OF THE BLADDER | |
RU2010135831A (en) | METHODS, MEDICINAL FORMS AND KITS FOR INTRODUCING ZIPRASIDONE WITHOUT FOOD | |
WO2004017896A3 (en) | Combination therapy using a dual ppar alpha/gamma agonist and an angiotensin ii type i receptor antagonist | |
EA200600817A1 (en) | ANTAGONISTS B1 BRADIKININ RECEPTOR (OPTIONS), PHARMACEUTICAL COMPOSITION, MEDICINAL MEDICINE, METHOD OF TREATMENT OF DISEASES (OPTIONS) | |
RU2007119067A (en) | MEANS FOR TREATMENT OF AN IRRITATED INTESTINAL SYNDROME WITH PREVENTION OF DIARRHEA | |
AR038858A1 (en) | COMBINATION | |
NO20071889L (en) | Remedy for prophylaxis or treatment of metabolic syndrome. | |
TH83710B (en) | Combined therapy | |
Wuerzner et al. | Renin inhibition with aliskiren. | |
Beltrame Ribeiro | Angiotensin II antagonists–therapeutic benefits spanning the cardiovascular disease continuum from hypertension to heart failure and diabetic nephropathy | |
TH83710A (en) | Combined therapy | |
TR200301553A1 (en) | New oral pharmaceutical formulations containing irbesartan active ingredient | |
RU2003130641A (en) | KAPPA-OPIATE AGONISTS FOR TREATMENT OF DISEASES OF THE BLADDER | |
Hernandez-Hernandez et al. | Angiotensin II receptor antagonists in arterial hypertension | |
DE60327249D1 (en) | ANTHRANILIC ACID AMIDE AND ITS PHARMACEUTICAL USE | |
EA200700524A1 (en) | PREPARATIONS FOR ORAL APPLICATION WITH EFFECT OF SLOW-EFFECTS AT TAKING API API TOGETHER WITH FOOD | |
REID | New therapeutic agents for hypertension |